1-4 of 4
Authors: Eric Maller
Journal Article
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies Open Access
Inflammatory Bowel Diseases, Volume 27, Issue 7, July 2021, Pages 983–993, https://doi.org/10.1093/ibd/izaa193
Published: 14 August 2020
Journal Article
P113 EVALUATION OF THE EFFICACY OF TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS UTILIZING THE MODIFIED MAYO SCORE: DATA FROM THE OCTAVE PROGRAM Get access
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S17–S18, https://doi.org/10.1093/ibd/zaa010.041
Published: 23 January 2020
Journal Article
P068 EXTRAINTESTINAL MANIFESTATIONS AND THEIR IMPACT ON REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH ULCERATIVE COLITIS Get access
Inflammatory Bowel Diseases, Volume 25, Issue Supplement_1, February 2019, Page S33, https://doi.org/10.1093/ibd/izy393.075
Published: 07 February 2019
Journal Article
14 POST-HOC ANALYSIS OF TOFACITINIB CROHN’S DISEASE PHASE 2 INDUCTION EFFICACY IN SUBGROUPS WITH BASELINE ENDOSCOPIC OR BIOMARKER EVIDENCE OF INFLAMMATION Get access
Inflammatory Bowel Diseases, Volume 24, Issue suppl_1, February 2018, Pages S56–S57, https://doi.org/10.1093/ibd/izy037.024
Published: 18 January 2018
